InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Suliman Shehnaaz, Director. Director active across 3 companies, notably Alector, Inc.. In total, 18 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €120k. History available since 7 May 2021. The latest transaction was filed on 24 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Suliman Shehnaaz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
561 shares@ US$62.7259Class A Common StockSEC:0001610717-26-000389:0
1,646 shares@ US$63.9664Class A Common StockSEC:0001610717-26-000389:1
364 sharesClass A Common StockSEC:0001610717-26-000242:1
5,359 sharesClass A Common StockSEC:0001610717-26-000242:0
8,829 shares0Class A Common StockSEC:0001610717-26-000195:0
15,357 shares0Class A Common StockSEC:0001610717-25-000171:0
5,740 shares0Common StockSEC:0000950170-25-074669:0
5,345 shares0Common StockSEC:0000950170-24-075483:0
8,649 shares0Class A Common StockSEC:0001610717-24-000327:0
1,865 shares0Class A Common StockSEC:0001610717-23-000176:0
3,860 shares0Common StockSEC:0001209191-23-035689:0
3,300 shares0Common StockSEC:0001209191-22-039562:0
2,120 shares0Class A Common StockSEC:0001567619-22-013120:0
75,000 shares@ US$17.2379.1% of flowCommon StockSEC:0001209191-21-069643:0
19,813 shares@ US$17.2320.9% of flowCommon StockSEC:0001209191-21-069130:0
2,145 shares0Common StockSEC:0001209191-21-043535:0
625 shares0Class A Common StockSEC:0001209191-21-040697:0
100,000 shares0Common StockSEC:0001209191-21-031839:0
18 of 18 declarations
About Suliman Shehnaaz
SULIMAN SHEHNAAZ is Directeur Général, Président et Administrateur. He is linked to 10x Genomics, Inc., Ultragenyx Pharmaceutical Inc. and Alector, Inc. The declarant has 16 filings in total, and across the recent filings tracked, the period runs from 2021-05-11 to 2026-06-18, with buy volume of EUR 0 and sell volume of EUR 0. The most frequent transaction nature is Attribution.
